South Korea Uterine Cancer Diagnostics Market to 2032
Overview
The South Korea Uterine Cancer Diagnostics Market is expected to reach a 312.28 USD Million by 2032 and is projected to grow at a CAGR of 14.51% from 2025 to 2032.
Revenue, 2024 (USD Million)
145.83
Forecast, 2032 (USD Million)
312.28
CAGR, 2024 - 2032
14.51%
Report Coverage
South Korea
South Korea Uterine Cancer Diagnostics Market 2018-2032 USD Million
South Korea Uterine Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 145.83 USD Million
- Projected Market Size (2032): 312.28 USD Million
- CAGR (2025-2032): 14.51%
Key Findings of South Korea Uterine Cancer Diagnostics Market
- The South Korea Uterine Cancer Diagnostics Market was valued at 145.83 USD Million in 2024.
- The South Korea Uterine Cancer Diagnostics Market is likely to grow at a CAGR of 14.51% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Endometrial Cancer in Type Segment accounted for the largest share of the market with a revenue of 586.12 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 17.68% during the forecast period from 2024 to 2032.
South Korea Uterine Cancer Diagnostics Market Scope
South Korea Uterine Cancer Diagnostics Market Segmentation & Scope
Type
- Uterine Sarcoma
- Endometrial Cancer
End User
- Others
- Specialized Clinics
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
Age Group
- <30 Years
- 31-40 Years
- 41-50 Years
- 51-60 Years
- >60 Years
Diagnostic
- Procedure Based
- Instrument-Based
Distribution Channel
- Others
- Third Party Distributors
- Direct Tender
South Korea Uterine Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 145.83 USD Million |
| Market Value in 2032 | 312.28 USD Million |
| CAGR (2025-2032) | 14.51% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,End User,Age Group,Diagnostic,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 145.83 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 145.83 USD Million in 2024.
Segments and Scope
-
South Korea Uterine Cancer Diagnostics Market to 2032, By Type
- Endometrial Cancer is the largest segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a revenue of 586.12 USD Million in the year 2024.
- Uterine Sarcoma is the Fastest growing segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 14.51 % in forecast period 2025-2032.
-
South Korea Uterine Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a revenue of 64.12 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 17.68 % in forecast period 2025-2032.
-
South Korea Uterine Cancer Diagnostics Market to 2032, By Age Group
- >60 Years is the largest segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a revenue of 63.00 USD Million in the year 2024.
- >60 Years is the Fastest growing segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 16.67 % in forecast period 2025-2032.
-
South Korea Uterine Cancer Diagnostics Market to 2032, By Diagnostic
- Instrument-Based is the largest segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a revenue of 84.11 USD Million in the year 2024.
- Instrument-Based is the Fastest growing segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 15.57 % in forecast period 2025-2032.
-
South Korea Uterine Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a revenue of 66.95 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in South Korea Uterine Cancer Diagnostics Market to 2032 with a Growth rate of 17.43 % in forecast period 2025-2032.
South Korea Uterine Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Koninklijke Philips N.V. | |||
| CANON MEDICAL SYSTEMS CORPORATION | |||
| General Electric | |||
| F. Hoffmann-La Roche Ltd. | |||
South Korea Uterine Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Uterine Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Uterine Cancer Diagnostics Market is segmented based on Segmentation Type,End User,Age Group,Diagnostic,Distribution Channel.
South Korea Uterine Cancer Diagnostics Market was valued at USD 145.83(Revenue in USD Million) in 2021.
South Korea Uterine Cancer Diagnostics Market is projected to grow at a CAGR of 14.51% during the forecast period of 2024 to 2032.
The Endometrial Cancer segment is expected to dominate the South Korea Uterine Cancer Diagnostics Market, holding a largest market share of 586.12 USD Million in 2024
South Korea Uterine Cancer Diagnostics Market Scope
South Korea Uterine Cancer Diagnostics Market Segmentation & Scope
Type
- Uterine Sarcoma
- Endometrial Cancer
End User
- Others
- Specialized Clinics
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
- Hospitals
Age Group
- <30 Years
- 31-40 Years
- 41-50 Years
- 51-60 Years
- >60 Years
Diagnostic
- Procedure Based
- Instrument-Based
Distribution Channel
- Others
- Third Party Distributors
- Direct Tender
Frequently Asked Questions
The South Korea Uterine Cancer Diagnostics Market is segmented based on Segmentation Type,End User,Age Group,Diagnostic,Distribution Channel.
South Korea Uterine Cancer Diagnostics Market was valued at USD 145.83(Revenue in USD Million) in 2021.
South Korea Uterine Cancer Diagnostics Market is projected to grow at a CAGR of 14.51% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Uterine Cancer Diagnostics Market for final year is USD 312.28 (USD Million).
South Korea Uterine Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The South Korea Uterine Cancer Diagnostics Market is segmented based on Segmentation Type,End User,Age Group,Diagnostic,Distribution Channel.
South Korea Uterine Cancer Diagnostics Market was valued at USD 145.83(Revenue in USD Million) in 2021.
South Korea Uterine Cancer Diagnostics Market is projected to grow at a CAGR of 14.51% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Uterine Cancer Diagnostics Market for final year is USD 312.28 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.